NCAM1 and lung cancer: Our results with regard to the decreases in the numbers and function of the studied CD4 + and CD8 + T cells as well as NK cells are in line with results from a previous study which concluded that the numbers of circulating T, NK and CD56+T cells and their levels of GzB expression are decreased in lung cancer patients.